The delisting is a routine procedural filing completing an already-executed take-private. No further trading opportunity exists in SEM common stock. Holders who did not tender should contact their broker regarding receipt of the $16.50 merger consideration. Monitor for any subsequent filings related to deregistration or appraisal rights.
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Select Medical Holdings Corp (SEM) filed Form 25-NSE with the NYSE to remove its common stock from listing and registration, effective July 13, 2026, following completion of the take-private merger with an affiliate of Welsh, Carson, Anderson & Stowe on July 1, 2026. Each SEM share was converted into $16.50 cash, the stock was suspended from trading on July 1, 2026, and the company will deregister its securities. This is the final procedural step of the going-private transaction announced in the prior 8-K.
Key Facts
- NYSE filed Form 25-NSE to delist SEM common stock effective July 13, 2026
- Merger with Stallion MergerSub Corp closed and became effective July 1, 2026
- Each share converted into $16.50 cash, trading suspended July 1, 2026
- Select Medical becomes wholly-owned indirect subsidiary of WCAS XIV, L.P.
- This is the final administrative step of the take-private transaction
Financial Impact
Shareholders received $16.50 per share cash; ~18% premium to unaffected price per prior filing context; entire $2.0B market cap extinguished at deal close
Risk Factors
- No further public market for SEM shares
- Potential appraisal/valuation disputes for dissenting shareholders
- Completion of deregistration removes all SEC reporting obligations
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 25-NSE Filing (Primary) | 0000876661-26-000585 |
| Document: 0000876661-26-000585-index.html | 0000876661-26-000585 |
| Document: 0000876661-26-000585.txt | 0000876661-26-000585 |
Track record
8 reports on SEM
2 of 3 bullish or bearish reports moved the stock their way by T+20. Best: +1.54% at T+60 after the Mar 3, 2026 report. 3 of 4 went positive at some point.
Filters
- Jul 13, 202618w ago 15-12G Neutral 4/10 No price data
- Jul 1, 202619w ago 25-NSE Neutral 9/10 Viewing Entry $16.52 No price data
- Jul 1, 202619w ago 8-K Bullish 8/10 Entry $16.52 No price data
- Jun 26, 202620w ago 8-K Bullish 7/10 Entry $16.53 No price data
- Apr 30, 202628w ago 8-K Bearish 6/10 Entry $16.38 to $16.51 ▼ −0.81% +4.45% vs SPY
- Apr 15, 202630w ago PREM14A Bullish 8/10 Entry $16.38 to $16.45 ▲ +0.43% −5.62% vs SPY
- Mar 4, 202636w ago DEFA14A Neutral 3/10 Entry $16.25 to $16.29 ▲ +0.25% +4.66% vs SPY
- Mar 3, 202636w ago DEFA14A Bullish 9/10 Entry $16.26 to $16.29 ▲ +0.18% +4.59% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers